A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy
Titel:
A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy
Auteur:
Aapro, M. Rugo, H. Rossi, G. Rizzi, G. Borroni, M.E. Bondarenko, I. Sarosiek, T. Oprean, C. Cardona-Huerta, S. Lorusso, V. Karthaus, M. Schwartzberg, L. Grunberg, S.